Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1475-2867
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT ; volume:20 ; number:1 ; day:27 ; month:10 ; year:2020 ; pages:1-17 ; date:12.2020
Cancer cell international ; 20, Heft 1 (27.10.2020), 1-17, 12.2020

Creator
Zhang, Renjie
Wang, Zijian
You, Wenjie
Zhou, Fengfang
Guo, Zicheng
Qian, Kaiyu
Xiao, Yu
Wang, Xinghuan
Contributor
SpringerLink (Online service)

DOI
10.1186/s12935-020-01607-y
URN
urn:nbn:de:101:1-2020121119020953344011
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Zhang, Renjie
  • Wang, Zijian
  • You, Wenjie
  • Zhou, Fengfang
  • Guo, Zicheng
  • Qian, Kaiyu
  • Xiao, Yu
  • Wang, Xinghuan
  • SpringerLink (Online service)

Other Objects (12)

MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression

MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression

Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway

Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways

Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers

Correction: Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways

Correction: Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways

Capsaicin combined with cisplatin inhibits TGF-β1-induced EMT and TSCC cells migration via the Claudin-1/PI3K/AKT/mTOR signaling pathway

Capsaicin combined with cisplatin inhibits TGF-β1-induced EMT and TSCC cells migration via the Claudin-1/PI3K/AKT/mTOR signaling pathway

HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway

HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway

Focal adhesion kinase inhibitor BI 853520 inhibits cell proliferation, migration and EMT process through PI3K/AKT/mTOR signaling pathway in ovarian cancer

Focal adhesion kinase inhibitor BI 853520 inhibits cell proliferation, migration and EMT process through PI3K/AKT/mTOR signaling pathway in ovarian cancer

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis

Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma

Hochschulschrift

Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma

Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma

Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma

Related objects